Breast Mass
Find comprehensive information on breast mass, breast lump, breast nodule, and breast tumor diagnosis. This resource covers healthcare best practices for clinical documentation and medical coding related to breast masses. Learn about identifying, evaluating, and documenting breast lumps and nodules for accurate medical coding and optimal patient care. Explore relevant clinical terminology and coding guidelines for breast tumor diagnosis.
A palpable or imageable abnormal mass of breast tissue.
Painless lump, swelling, nipple changes, skin dimpling, or redness.
Primary care, breast clinic, imaging center, or hospital.
ICD-10 Code Families
Complete code families applicable to N63.0
When to use each related code
| Description | When to use |
|---|---|
| Mass in breast tissue. | Use for palpable or imaging-detected mass. Includes lumps, nodules, and tumors. |
| Nipple discharge not associated with lactation. | Use for any non-milk nipple discharge. Specify color and laterality. Consider duct ectasia or papilloma. |
| Pain in the breast. | Document breast pain location and characteristics. May be cyclical or non-cyclical. Often benign, but investigate concerning features. |
Best-practice checklist
- ✓Document mass location (e.g., quadrant, clock face).
- ✓Record size in centimeters (measured in three dimensions).
- ✓Describe shape, texture, mobility, and tenderness.
- ✓Note associated symptoms (e.g., nipple discharge, skin changes).
- ✓Include imaging findings (mammogram, ultrasound, MRI).
Common pitfalls to avoid
Missing documentation of right, left, or bilateral breast involvement can lead to coding and billing errors.
Documenting "mass" without specifying benign or malignant necessitates further clarification for accurate coding.
Lack of documentation regarding size, shape, and characteristics of the mass may impact accurate code assignment and staging.
Best-practice tips
- 01Complete breast exam documentation: size, location, texture.
- 02Image guided biopsy for accurate diagnosis coding (ICD-10-CM).
- 03Distinguish benign vs. malignant: crucial for CDI, HCC compliance.
- 04Document family history, hormonal status for risk assessment.
- 05Correlate imaging, pathology reports for comprehensive record.
Step-by-step checklist
- 1
Confirm laterality (right/left breast) and location.
- 2
Document mass size, shape, and consistency.
- 3
Assess nipple discharge, skin changes, lymphadenopathy.
- 4
Correlate imaging findings (mammogram, ultrasound).
- 5
Consider biopsy for definitive diagnosis.
Ready-to-paste narrative
Patient presents with a complaint of a breast mass, also described as a breast lump or breast nodule. Onset of the mass is [duration and onset details - e.g., gradual over the past 3 months, sudden onset last week]. Location of the mass is [location details - e.g., upper outer quadrant of the left breast, periareolar region of the right breast]. Patient reports [presence or absence of pain - e.g., associated tenderness, no pain]. Other symptoms include [list associated symptoms, if any - e.g., nipple discharge, skin changes, axillary lymphadenopathy]. Physical examination reveals [objective findings - e.g., a palpable, firm, mobile, 2 cm mass in the left breast, no nipple retraction, no skin dimpling]. Family history is significant for [family history details - e.g., mother diagnosed with breast cancer at age 50, no family history of breast cancer]. Differential diagnosis includes fibroadenoma, breast cyst, lipoma, and breast cancer. Ordered [diagnostic tests - e.g., mammogram, breast ultrasound, biopsy] to evaluate the breast mass and rule out malignancy. Patient education provided regarding breast self-examination, clinical breast exam frequency, and the importance of follow-up. Plan to discuss results of diagnostic imaging and biopsy with the patient and determine appropriate management, which may include further imaging, fine-needle aspiration, core needle biopsy, surgical excision, or referral to a breast specialist. ICD-10 code N10.89, other specified disorders of breast, is considered pending further diagnostic evaluation. CPT codes for the evaluation and management visit, diagnostic imaging, and procedures will be assigned based on services provided.
Common questions and answers
What is the recommended diagnostic workup for a palpable breast mass in a 35-year-old woman, considering both benign and malignant etiologies?+
The diagnostic workup for a palpable breast mass in a 35-year-old woman should consider both benign and malignant etiologies and typically involves a triple assessment. This includes a thorough clinical breast exam, high-quality imaging (mammography with targeted ultrasound, or ultrasound alone if the patient is under 40), and tissue sampling (core needle biopsy or fine-needle aspiration). The specific imaging modality and biopsy technique chosen may depend on factors such as patient age, mass characteristics (size, location, consistency), and family history. Explore how risk stratification tools, such as the Breast Imaging Reporting and Data System (BI-RADS), can further guide management decisions and ensure timely diagnosis and treatment if necessary. Consider implementing a standardized diagnostic pathway in your practice for efficient and comprehensive breast mass evaluation.
How can I differentiate between a fibroadenoma and a breast cyst using ultrasound characteristics, and when is biopsy indicated for definitive diagnosis?+
Ultrasound can often differentiate between a fibroadenoma and a breast cyst. Fibroadenomas typically appear as solid, oval, or round masses with well-defined margins, homogeneous internal echoes, and potential posterior enhancement. Breast cysts usually present as anechoic (dark), round or oval lesions with well-defined margins, posterior acoustic enhancement, and occasionally, internal septations. However, overlapping features can make definitive diagnosis challenging. A biopsy (core needle biopsy is preferred) is generally indicated when ultrasound findings are inconclusive, the mass is complex or suspicious, or the patient experiences persistent symptoms. Learn more about the ACR BI-RADS lexicon and how it categorizes ultrasound findings to standardize reporting and guide appropriate management decisions.
What are the key factors to consider when choosing between core needle biopsy and fine needle aspiration for breast mass tissue diagnosis, and what are the potential complications of each procedure?+
Choosing between core needle biopsy (CNB) and fine needle aspiration (FNA) depends on several factors. CNB provides larger tissue samples, allowing for more accurate histological evaluation and assessment of architectural features, which is crucial for diagnosing certain lesions like atypical ductal hyperplasia or lobular carcinoma in situ. FNA is less invasive but yields smaller samples, potentially leading to insufficient material for diagnosis or underestimation of malignancy. Potential complications for both procedures include bleeding, bruising, infection, and pneumothorax (rarely). CNB also carries a slightly higher risk of scarring. Consider implementing a patient-centered approach to discuss the benefits and risks of each procedure and tailor the choice based on individual patient characteristics and lesion characteristics. Explore how the latest advancements in vacuum-assisted biopsy devices are improving tissue acquisition and minimizing complications.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.